Dr. Amy E. Colson, MD

Dr. Colson practices at CHA Cambridge Hospital in Cambridge, Massachusetts, part of Cambridge Health Alliance.

Dr. Colson's NPI, 1760557185, was assigned on November 21, 2006. Dr. Colson graduated from Harvard Medical School in 1993. Dr. Colson holds Massachusetts license 151074.

Dr. Colson's primary practice is CHA Cambridge Hospital, at 1493 Cambridge Street, Cambridge, MA 02139 in Middlesex County. The practice phone is (617) 665-1000.

Dr. Colson's primary practice is CHA Cambridge Hospital in Cambridge, Massachusetts, part of Cambridge Health Alliance. The medical group on file is Cambridge Health Alliance. Dr. Colson's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Colson practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Colson's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Colson is board certified in internal medicine by the American Board of Internal Medicine. Dr. Colson is licensed in Massachusetts.

Dmand AI lists alcohol use disorders, anxiety, chronic diabetes, chronic hypertension, chronic respiratory failure, cirrhosis of the liver, high cholesterol and hiv/aids among the conditions Dr. Colson treats.

CMS data shows 48 Medicare services from Dr. Colson across 1 procedure code in 2024, all of them office visits, for 19 Medicare patients. Medicare paid $3,602 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 19 Medicare patients who saw Dr. Colson in 2024. 68% of them have high blood pressure, and 58% have mood disorders. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Colson's median patient age at 48, with 29% women.

In 2024, Dr. Colson wrote 747 Medicare Part D claims for 31 patients. 57% of them were for generic drugs. CMS names the drug for 525 of them, across 21 drugs with 11 or more claims each, at $838,451 in total drug cost. In 2023, CMS named 619 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Colson for performance year 2024, reported as part of a group. Dr. Colson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Colson as offering telehealth.

Dmand AI links 8 papers to Dr. Colson in 2025. The most frequent topics are HIV Infections, HIV-1 and Anti-HIV Agents. Dr. Colson has published most often in AIDS. Dr. Colson's most frequent co-authors are Joshua James Gruber, MD, Megan Eng-Ling Chen, MD and Calvin J. Cohen, MD.

CMS Open Payments shows 220 general payments to Dr. Colson from 7 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 55% of the total. ViiV Healthcare Company paid the most, $138,686.

Dr. Colson graduated from Harvard Medical School in 1993.

Dr. Colson is in network with 6 carriers, including Aetna, Molina and United Healthcare. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.